XML 14 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
At-the-Market Public Offering [Member]
Private Placement [Member]
Common Stock [Member]
Common Stock [Member]
At-the-Market Public Offering [Member]
Common Stock [Member]
Private Placement [Member]
Additional Paid in Capital [Member]
Additional Paid in Capital [Member]
At-the-Market Public Offering [Member]
Additional Paid in Capital [Member]
Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2023 $ 126,481     $ 20     $ 785,199     $ 15 $ (658,753)
Beginning balance, units at Dec. 31, 2023       20,386,606              
Issuance of common stock, net of issuance costs 3,056   $ 89,454 $ 1   $ 17 3,055   $ 89,437    
Issuance of common stock, net of issuance costs, units       350,664   16,973,103          
Issuance of pre-funded warrants in public offering/private placement 14,293           14,293        
Vesting of restricted stock, units       98,677              
Exercises of common stock options 151           151        
Exercises of common stock options, units       24,639              
Unrealized gain (loss) on available-for-sale securities (19)                 (19)  
Equity-based compensation expense 1,611           1,611        
Net loss (24,303)                   (24,303)
Ending balance at Mar. 31, 2024 210,724     $ 38     893,746     (4) (683,056)
Ending balance, units at Mar. 31, 2024       37,833,689              
Beginning balance at Dec. 31, 2024 137,246     $ 40     920,609     47 (783,450)
Beginning balance, units at Dec. 31, 2024       40,468,141              
Issuance of common stock, net of issuance costs 135,367 $ 246   $ 36     135,331 $ 246      
Issuance of common stock, net of issuance costs, units       35,739,810 61,542            
Issuance of pre-funded warrants in public offering/private placement 52,590           52,590        
Issuance of common stock in private placement for payment of developmental milestone consideration $ 5,000     $ 1     4,999        
Issuance of common stock in private placement for payment of developmental milestone consideration, units       975,496              
Vesting of restricted stock, units       247,970              
Exercises of common stock options, units 0                    
Unrealized gain (loss) on available-for-sale securities $ (45)                 (45)  
Equity-based compensation expense 3,341           3,341        
Net loss (39,282)                   (39,282)
Ending balance at Mar. 31, 2025 $ 294,463     $ 77     $ 1,117,116     $ 2 $ (822,732)
Ending balance, units at Mar. 31, 2025       77,492,959